Abstract
Protein kinase C (PKC) modulates growth, differentiation, and apoptosis in a cell-specific fashion. Overexpression of PKC-α in MCF-7 breast cancer cells (MCF-7-PKC-α cell) leads to expression of a more transformed phenotype. The response of MCF-7 and MCF-7-PKC-α cells to phorbol esters (TPA) was examined. TPA-treated MCF-7 cells demonstrated a modest cytostatic response associated with a G1 arrest that was accompanied by Cip1 expression and retinoblastoma hypophosphorylation. While p53 was detected in MCF-7 cells, evidence for TPA-induced stimulation of p53 transcriptional activity was not evident. In contrast, TPA treatment induced death of MCF-7-PKC-α cells. Bryostatin 1, another PKC activator, exerted modest cytostatic effects on MCF-7 cells while producing a cytotoxic response at low doses in MCF-7-PKC-α cells that waned at higher concentrations. TPA-treated MCF-7-PKC-α cells accumulated in G2/M, did not express p53, displayed decreased Cip1 expression, and demonstrated a reduction in retinoblastoma hypophosphorylation. TPA-treated MCF-7-PKC-α cells expressed gadd45 which occurred before the onset of apoptosis. Thus, alterations in the PKC pathway can modulate the decision of a breast cancer cell to undergo death or differentiation. In addition, these data show that PKC activation can induce expression of gadd45 in a p53-independent fashion.
Original language | English (US) |
---|---|
Pages (from-to) | 1874-1886 |
Number of pages | 13 |
Journal | Journal of Clinical Investigation |
Volume | 96 |
Issue number | 4 |
DOIs | |
State | Published - Oct 1995 |
Keywords
- Apoptosis
- Breast cancer
- Phorbol esters
- Protein kinase C
- p53
ASJC Scopus subject areas
- Medicine(all)